+ All Categories
Home > Documents > Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID...

Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID...

Date post: 21-Feb-2021
Category:
Upload: others
View: 20 times
Download: 0 times
Share this document with a friend
15
1 © 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose. Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior Associate Dean for Research & Scholarship Kaiser Permanente Bernard J. Tyson School of Medicine Kaiser Permanente International Fireside Chat — September 22, 2020
Transcript
Page 1: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

1© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Kaiser Permanente Research

Kaiser Permanente Research During COVIDElizabeth A. McGlynn, PhD

Vice President, Kaiser Permanente ResearchInterim Senior Associate Dean for Research & ScholarshipKaiser Permanente Bernard J. Tyson School of Medicine

Kaiser Permanente International Fireside Chat — September 22, 2020

Page 2: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

2© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Kaiser Permanente Research Fast Facts, 2019

aRefers to the 8 regional research centersbRefers to total count of articles in the Kaiser Permanente Publications Library available at https://kpresearchpublications.kp.org/

38% Clinical trials

80Full-time research leaders

1,670Research

support staff

&

$58 MOther externally funded research

$89 MKaiser Permanente

support

$127 MFederally-funded

research

1,890Journal articles

published in 2019

19,020Articles total since 2000b

&

Funding in 2019a

62%Other studiesa

Research Studies Underway in 2019

Research Personnela Research Publications

$274

Million2,620

Studies

Page 3: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

3© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Kaiser Permanente is Engaged in Research on SARS-CoV-2, COVID

Existing research teams and infrastructure enabled rapid engagement

• Clinical trials

– Vaccine candidates

–New or repurposed treatments

• Operational input

– Surge planning

– Changes in telehealth use

– Tracking disparities, outcomes

• Observational studies

–Understanding risk factors for COVID

– Examining changes in care for other conditions

Page 4: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

4© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Clinical Trials Undertaken in Vaccines & Treatments

Vaccine Trials Treatment Trials (selected)• NIAID/Moderna

– Phase 1 trial started March 16, 2020 at KPWA

• Preliminary report in NEJM on July 14, 2020 found vaccine was well tolerated and generated an immune response

– Phase 1 trial extended to older adults starting April 16, 2020

– Phase 3 trial started in July 2020

• Pfizer/BioNTech

– Phase 3 trial started in August 2020

– 3 regions engaged: KPNC, KPSC, KPNW

• Ongoing discussions around other potential vaccine trials

• NIAID/Gilead/Remdesivir

– Phase 3 trial started on March 22, 2020 in KPSC for patients with moderate or severe disease

– KPNC joined the trial later; other regions participated through contract hospitals

• NIAID ACTT2 (Remdesivir + Baricitinib)

– Started June 22 in KPNW

– Inhibit cytokine inflammatory response

• Selinexor

– KPNC trial; testing anti-inflammatory response in patients hospitalized with moderate to severe COVID-19

• MITIGATE COVID-19

– KPNC patients with atherosclerotic cardiovascular disease with no prior history of COVID-19; studying effect on rate of moderate to severe upper respiratory tract infection

KP has been engaged in multiple vaccine and treatment trials

Page 5: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

5© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

We’ve Published on a Variety of COVID-Related Topics (A Sampler)

Page 6: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

Kaiser Permanente Colorado RegionCARING Conversations

Innovation during COVID-19

Meri NomiCare Management Institute

6 | Copyright © 2020 Kaiser Permanente Care Management Institute .

September 22, 2020

Page 7: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

CARING Conversations | Proactive Outreach to Elderly and Seriously Ill Patients

Proactive outreach goals of care conversations by Primary Care Physicians, Physician Assistants, RNs, LCSWs, & others with just-in-time training

Target outreach population includes > age 70 with a significant burden of underlying chronic disease, & other high-risk patients as appropriate

Support includes assistance with Advance Care Planning (ACP), social non-medical needs, behavioral health, pharmacy, and Supportive (Palliative) Care services

C Check In

A Assess need for information or support

R Review prior ACP / identify decision maker

I Identify what matters most and preferences for care

N Note recommendations and decisions in problem list

G Give thanks and reaffirm your commitment to their care

7 | Copyright © 2020 Kaiser Permanente Care Management Institute

Page 8: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

CARING Conversations | Data, Member and Provider Experience

8 | Copyright © 2020 Kaiser Permanente Care Management Institute

6000+ CARING Conversations completed from April 8, 2020 through May 31, 2020

96% of CARING Conversations resulted in verbal designation of decision maker

Members were thinking about their goals and values and were grateful for the conversation.

Insights from Member and Provider Interviews

Providers managed their anxiety and found these goals of care conversations to be some of the most rewarding work of their medical careers.

Having a caring, welcoming, thoughtful demeanor was important for the connection to be made and the conversation to be successful.

To do this well, providers need dedicated time in their schedules and an easy process to have these conversations.

Providers understand the effort to know, respect and guide patients is an important part of honoring patient wishes.

Page 9: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

CARING Conversations | Success Factors

9 | Copyright © 2020 Kaiser Permanente Care Management Institute

Document in consistent place in the EMR and write the order

Telephone calls make it easy for provider to read from script

Use an App - number recognizable as KP

Heads up to member that provider is going to call- Schedule the call with member

Team up with others to exchange ideas- What went well, what didn’t go so well- How to handle awkward moments

Have a simple process to make it easy- Generate outreach list- Technology in place – concentrate on conversation- Script provides framework for conversations

Have a separate conversation just focused on goals of care and periodically update and continue the conversation

Provide time in the workflow for conversations

kp

CARING Conversations required minimal investment for training and are an excellent example of sustainable quality, experience & service.

Page 10: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

Kaiser Permanente Equitable Care InitiativesA presentation to KP International

Nicole Barnett, DHSc, MBA, RN, CNL

Regional Director Nursing and Clinical Practice

© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Page 11: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

Living in a “Dual Pandemic”• Systemic Racism

• Covid-19

© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

Page 12: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

We were founded on delivering equitable care and inclusion for all

• In the 1940s, Sidney Garfield, MD and Henry Kaiser committed to building a unique health care system that would deliver the highest standard of care and be accessible to everyone without discrimination.

• This was a bold approach at a time of rampant racial segregation and gender inequities in America.

Page 13: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

We care for a significant portion of all Northern California residents

27% foreign born

22% of adults have a

disability

5+% identifies as

LGBTQ

There is no majority

ethnic group

19% speak English

“less than very well”

Age 65+ is increasing

significantly

California ranks the most diverse state in 2019 on

the factors of socio-economic diversity, cultural

diversity, economic diversity, household diversity,

religious and political diversity.

13

Page 14: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

PATIENTS

PEOPLE

COMMUNITY

Making sure that the care that we deliver is culturally informed and promotes health equity

Creating work environments that respect the unique backgrounds and experiences of our staff and physicians

Structuring community relationships and engagement opportunities that are data informed and address areas of inequity

© 2020. Kaiser Permanente. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose. 14

Page 15: Kaiser Permanente Research...Kaiser Permanente Research Kaiser Permanente Research During COVID Elizabeth A. McGlynn, PhD Vice President, Kaiser Permanente Research Interim Senior

© 2020. Kaiser Permanente International. All Rights Reserved. This presentation is for educational purposes only and cannot be modified, used, or distributed for any other purpose.

#KPIHE2020


Recommended